Build status - In Progress

Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel

Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel
Enrolling By Invitation
18 years - 99 years
All
2 participants needed
1 Location

Brief description of study

Participants invited to participate in a research study must have diagnosis of multiple myeloma and have been previously treated with the study drug, cilta-cel. The purpose of this research is to monitor the health status of subjects who were previously enrolled in cilta-cel.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: myeloma
  • Age: 18 years - 99 years
  • Gender: All
Updated on 11 Oct 2024. Study ID: 850401
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research